Strokes are a major cause of death and disability and the third leading cause of death in western society. It is estimated 3% ...

Tissue plasminogen activator (TPA) may be given, but it must be administered within the first few hours ... These types of changes may be suggested to help control the effects of diabetes. The two ...

Patients considered for this study met the following criteria: (1) they had undergone MT for acute ischemic stroke, (2) had a pretreatment CT scan available with sufficient image quality and an ...

More people are surviving stroke to experience its long-term consequences, but outcomes in people living more >10 years after stroke have not been described in detail. Methods Data were collected for ...

Background: Thrombolysis with tissue plasminogen activator (tPA) remains the only approved drug therapy for acute ischemic stroke. However, delayed tPA treatment is associated with an increased risk ...

Table 2 Promotion neurogenesis with drugs after ischemic stroke. The proliferation of stem cells was the first step of neurogenesis. Neuroinflammation, neurotrophic factors and apoptosis- related ...

Two anti-psychotic drugs should not be used to treat older people with dementia due to an increased risk of stroke, medicines experts have warned. The Committee for the Safety of Medicines (CSM ...

Objectives Hepatic enzyme-inducing antiepileptic drugs (AEDs) increase serum lipid levels and other atherogenic markers via the induction of cytochrome P450 and may therefore increase the risk of ...

It can occur with prescription or nonprescription drugs. It can also range from mild to severe. Substance use disorder, formerly known as “drug abuse,” develops when substance use interferes ...

Many stroke survivors and families of stroke survivors worry about the safety of flying as a passenger in an airplane after a stroke. Is the concern warranted? It certainly is a common question, so ...

Introduction: Intravenous thrombolysis with alteplase (tPA) or tenecteplase (TNK) is a first-line treatment for acute ischemic stroke. The most serious risk associated with IV thrombolytics is ...